One of the highlights of the Ocala Breeders' Sales Co. Spring 2-Year-Olds in Training Sale was undone when buyer Larry Best of OXO Equine turned back the purchase of a $1.1-million Speightster colt, BloodHorse reports.
The purchase was voided under the Conditions of Sale after staff at Taylor Made Farm in Nicholasville, Ky., found the colt to be a cribber; a condition that was not announced at the time he was in the ring. Video was taken of the horse cribbing, and sent to the OBS staff, with Best formally announcing his intention to return the horse shortly before the end of the seven-day window to do so.
To learn more about cribbing in relationship to sales, click here.
Tom McCrocklin consigned the colt as agent for Solana Beach Sales, the pinhooking wing of the Little Red Feather Racing partnership. The colt will be sent to trainer Bob Baffert to begin his racetrack career. McCrocklin told BloodHorse that the colt had showed no signs of cribbing prior to the sale, thus an announcement was not warranted, but the sellers were happy to retain the horse to race.
Named Fortunate Son, the New York-bred colt is out of the stakes-placed Indian Charlie mare Auspicious, who is the dam of three winners from four foals to race. He sold for $110,000 at last year's Fasig-Tipton New York-Bred Yearling Sale.
Read more at BloodHorse.
The post Sale Voided On Seven-Figure Speightster Colt At OBS Spring Auction appeared first on Horse Racing News | Paulick Report.
The Food and Drug Administration has issued a warning letter to Pennsylvania-based Rapid Equine Solutions following its inspection of the facility last summer, asking the pharmacy to provide more information about what its employees are doing to prevent serious problems at the facility.
The letter, dated June 12 of this year, describes observations made by federal inspectors between July 22 and Aug. 9, 2019 that include “insanitary conditions,” “potency issues,” and misbranding. Inspectors described “an unknown white film on the floor in the sterile production room and debris in the corners of the room” as well as several bugs lingering around the sterile and non-sterile preparation areas, while fly tape hung from the ceiling above the laboratory sink.
Further, the letter notes that a batch of toltrazuril/pyrimethamine paste compounded for the treatment of horses with Equine Protozoal Myeloencephalitis (EPM) was found to have incorrect amounts of both ingredients in it per its labeling. There was only 3 percent of the declared amount of toltrazuril in the paste, but 2,122 percent the amount of pyrimethamine declared on the label. The investigation followed the deaths of three horses in Maine and Ohio who were given the paste.
The drug combination, which has proven a popular choice for treating EPM, is the same one that was formulated incorrectly in 2014 by a Kentucky compounder which released batches with too much pyrimethamine in them. At least four horses died and several more fell ill in that case.
Rapid Equine provided the FDA with responses outlining its plans for eliminating the problems identified by investigators, but the agency writes in its warning letter this month those responses don't include enough specific information about what the facility is doing to improve their processes.
In 2019, Maine regulators suspended Rapid Equine's license after they say they discovered the mail-order facility was acting as a wholesaler for compounded drugs and was selling large amounts of compounds to a harness veterinarian who sold them without a prescription. Compounded drugs are not FDA-approved and are not intended to be produced and sold or stored in bulk; rather, they should be formulated to order for a specific patient to treat a diagnosed condition as prescribed by a veterinarian.
According to the online license verification system for the Pennsylvania State Board of Pharmacy, regulators there have taken no disciplinary action against Rapid Equine's license, which was renewed in August 2019 — on the same day FDA inspectors concluded their observation of the pharmacy's unsanitary conditions.
Read the June 2020 FDA warning letter here.
The post FDA Issues Warning Letter To Rapid Equine Solutions After Finding Dirty Compounding Rooms, Potency Issues appeared first on Horse Racing News | Paulick Report.
Canadian Hall of Fame jockey Don Seymour, who stamped himself one of the nation’s leading riders after riding two Triple Crown winners, died June 26 at his home in Barrie, Ontario. Surrounded by his family, including his mother Mary, at the time of his death, he reportedly had been suffering from chronic obstructive pulmonary disease since earlier this year. He was 59.
Born and raised in Hamilton, Ontario, Seymour was a leading rider in Alberta in the 1980s before relocating to ride at Woodbine Racetrack in Etobicoke, Ontario. Best remembered for sweeping consecutive Triple Crowns in 1988-89 with Kinghaven Farm runners With Approval and Izvestia–both horses would go on to be named Horses of the Year–he also accompanied Canadian champion Play The King, who finished second behind U.S. Sprint Champion Gulch in the 1988 GI Breeders’ Cup Sprint en route to Canadian Horse of the Year honors.
Voted the Sovereign Award-winning rider in 1985, 1987, 1989 and 1990, he was honored with the Avelino Gomez Memorial Award in 1995 and was inducted into the Canadian Horse Racing Hall of Fame in 1999. After an early retirement from the saddle in 1994 with 2,141 career wins, including 171 stakes wins, Seymour served as a placing judge and official clocker before leaving the track for good in 2002.
A private family service will be held followed by a public celebration of Seymour’s life at a later date. In his memory, donations may be made to the Heart and Stroke Foundation.
The post Canadian HOF Rider Don Seymour Dies appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
